Scroll Top

EntroGen: predictive, preventive and personalized kits support lung cancer therapies

EntroGen has developed a series of kits that identify somatic mutations in lung cancer and help guide targeted therapies for this type of malignancy.

nov-entrogen02
Training

EntroGen has developed a series of kits that identify somatic mutations in lung cancer and help guide targeted therapies for this type of malignancy.

At Biosystems Corp., we offer the following solutions to support lung cancer treatments:

– Real-time PCR assays

– EGFR mutation analysis kit

– Cell-Free EGFR Mutation Identification Kit

– PIK3CA mutation identification kit

– KRAS mutation analysis kit

– Lung Cancer RNA Panel

Source: http://www.entrogen.com/support/docs/Lung%20cancer%20assays%20v11222019.pdf